BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20735898)

  • 1. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
    Callum C; Boyle S; Sandford A
    Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future avoidable cost of smoking--estimates for Sweden 2007.
    Bolin K; Borgman B; Gip C; Wilson K
    Health Policy; 2011 Nov; 103(1):83-91. PubMed ID: 21959339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of smoking in Canada, 1991.
    Kaiserman MJ
    Chronic Dis Can; 1997; 18(1):13-9. PubMed ID: 9188515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs of smoking revisited.
    Phillips D; Kawachi I; Tilyard M
    N Z Med J; 1992 Jun; 105(936):240-2. PubMed ID: 1620500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The public health impact and economic cost of smoking in Connecticut--1989.
    Adams ML
    Conn Med; 1994 Apr; 58(4):195-8. PubMed ID: 8045117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
    Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
    Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess healthcare cost associated with a low smoking prevalence, Barbados.
    Lwegaba A
    West Indian Med J; 2004 Jan; 53(1):12-6. PubMed ID: 15114887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK.
    Turner DA; Shaw C; McGrother CW; Dallosso HM; Cooper NJ;
    BJU Int; 2004 Jun; 93(9):1246-52. PubMed ID: 15180616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of epilepsy misdiagnosis in England and Wales.
    Juarez-Garcia A; Stokes T; Shaw B; Camosso-Stefinovic J; Baker R
    Seizure; 2006 Dec; 15(8):598-605. PubMed ID: 17011217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital costs associated with smoking in veterans undergoing general surgery.
    Kamath AS; Vaughan Sarrazin M; Vander Weg MW; Cai X; Cullen J; Katz DA
    J Am Coll Surg; 2012 Jun; 214(6):901-8.e1. PubMed ID: 22502993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modelling of the costs of productivity losses due to smoking in Germany for the year 2005].
    Prenzler A; Mittendorf T; von der Schulenburg JM
    Gesundheitswesen; 2007 Nov; 69(11):635-43. PubMed ID: 18080936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking and lifetime medical expenditures.
    Hodgson TA
    Milbank Q; 1992; 70(1):81-125. PubMed ID: 1588892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan.
    Yang MC; Fann CY; Wen CP; Cheng TY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i62-70. PubMed ID: 15923452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of tobacco-related diseases, including passive smoking, in Hong Kong.
    McGhee SM; Ho LM; Lapsley HM; Chau J; Cheung WL; Ho SY; Pow M; Lam TH; Hedley AJ
    Tob Control; 2006 Apr; 15(2):125-30. PubMed ID: 16565461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking attributable mortality and economic costs in Alaska 1992-94.
    Schumacher C
    Alaska Med; 1996; 38(1):13-7. PubMed ID: 8936095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.